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INTRODUCTION 
 
Pseudoexfoliation  syndrome is an age related generalized disorder 
involving the eyes, particularly
1
.  It forms the most common cause of 
open angle glaucoma
2
. 
Apart from open and closed angle glaucoma, it also has intra-
operative and post-operative risks in the patients undergoing cataract 
surgery
1
. 
Pseudoexfoliation syndrome is associated with systemic disorders 
such as Hypertension, angina, coronary artery disease, retinal vascular 
disease, peripheral vascular disease
3
. Additonally, PEX is associated with 
sensorineural hearing loss
3
. 
Pseudoexfoliation is most commonly seen in old people, in their 
late 60s and early 70s. It may be unilateral or bilateral and 50% of them 
become bilateral over a period of 20 years
4
. In the eye, pseudoexfoliation 
is characterized clinically by progressive production and accumulation of 
small fibrillar extracellular material. Most commonly these dandruff like 
deposits are seen over the pupillary margin and the anterior lens 
capsule
3,5
. 
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The most consistent diagnostic feature is the targetlike pattern on 
the anterior capsule of the lens and they are best seen after pupillary 
dilation
3,5,6
. 
1. A central disc translucent in nature with occasional curled edges.  
2. Intermediate clear zone probably due to the movement of iris that 
rubs the material off.   
3. Peripheral granular zone with scalloped margins. 
Central zone is absent in 20% or more cases, but the peripheral  
zone is a more consistent finding. Hence it warrants dilation of the pupil  
for the examination to be complete
5
. 
  Pseudoexfoliation material is also seen over the corneal 
endothelium, ciliarybody, zonules, anterior vitreous face and angle 
structures. The associated features of pseudoexfoliation includes iris 
transillumination defect in the pupillary margin, poor pupillary dilatation, 
heterochromia  iris. 
More over the involved eye is miotic. Weak zonules with lens 
instability results in subluxation or dislocation  and variable chamber 
depth
3,5,6,7
. 
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Patients with pseudoexfoliation syndrome are notorious for 
development of pseudo exfoliation glaucoma hence these patients should 
be viewed as glaucoma suspects
8
. A complete ophthalmic examination 
including a slit lamp examination, Intra ocular pressure measurements, 
gonioscopy, visual field testing, optic nerve head examination with nerve 
fibre quantification is a must. 
Presence of secondary open-angle glaucoma is known as glaucoma 
capsulare
5
. PEX glaucoma has more serious and worse clinical prognosis 
than primary open-angle glaucoma, often not responding to medical 
management and requiring early surgical intervention 
3,5,6,7
. Angle closure 
glaucoma is also seen due to pupillary block by forward movement of 
lens
5
. Corneal endothelium  shows decreased cell count and 
pleomorphism leading to early corneal decompensation at moderate rise 
in intraocular pressure after cataract surgery
9
. An increased incidence of 
nuclear cataract was also seen in the eye with pseudoexfoliation
10
. 
Making the diagnosis of pseudoexfoliation is very important and 
requires a careful examination under slitlamp after pupillary dilation or 
otherwise it may go unnoticed  and results in unexpected complications. 
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REVIEW OF LITERATURE 
History: 
The history of pseudoexfoliation syndrome dates back to 1917 
when it was first described by Finnish ophthalmologist John 
G.Lindberg
11
. Inspired by his senior colleague Axenfeld, a german 
ophthalmologist he observed and described the grayish white flakes in the 
pupillary margin and over the surface of the anterior lens capsule in older 
patients. He thought it could be due to prior inflammation
11
. 
Alfred vogt, a swiss ophthalmologist made the full description of 
pseudo exfoliation
12
. Formerly, in 1918 he described it as remnants of 
pupillary membrane present over the surface of anterior lens capsule. 
Later in 1925, he described it as exfoliation of the lens capsule. He also 
mentioned the presence of deposits over iris, back of cornea and made an 
association with glaucoma
13
. 
In 1928, Busacca studied the pseudo exfoliation material 
histologically after staining with haemotoxylin and eosin. He described it 
as discrete pinkish mass, either sessile or pedunculated over the anterior 
lens surface without any capsular dehiscence
14, 16
. 
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In 1954, Georgiana Dvorak – Theobald coined the term “pseudo 
exfoliation”
15
. He differentiated it from true exfoliation of the lens 
capsule caused by infrared rays in glass blowers
15
. 
In 1964, Bertelsen, Drablos and Flood recommended the term 
fibrillopathia epithelio capsularis. He suggested pre equatorial lens 
epithelial cells produced the abnormal fibrillar substance
15
. 
In 1969, Vannas thought that the pseudo exfoliation material was 
blood borne since he observed abnormal leakage of fluorescein while 
doing iris fluorescence angiography
16
. 
In 1973 Ghosh and Speakman studied same peculiar changes in iris 
and ciliary body epithelium. This made them to propose that they are 
additional primary sites of pseudo exfoliation fibril
16
. 
Also in 1973 Ringvold observed deposition of pseudo exfoliation 
along the walls of conjunctival capillaries. The same findings were 
confirmed by Ghosh and Speakman in 1976
16
. 
In 1975 Pederson and Davanger studied under transmission 
electron microscopy and scanning electron microscopy. They commented 
“Pseudo exfoliation excrescences rest on a basal lamina”
 16
. 
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Eagle and colleagues believed that the material represented 
abnormal basement membrane secretions and hence they named it as 
basement membrane exfoliation syndrome.
17
 
Recent ultra structural studies indicate the material is derived from 
lens capsule and hence can be called as exfoliation syndrome. The term 
pseudo exfoliation and exfoliation syndrome are used interchangeably in 
current literature
5
. 
Renewed interest in studying the pseudoexfoliation syndrome in 
the late 80’s and 90’s lead to the establishment of International 
Association for the study of pseudoexfoliation syndrome named after 
Lindberg – The Lindberg’s Society
15
. 
Epidemiology: 
 The occurrence of Pseudo exfoliation syndrome is 
worldwide. But the rate of prevalence varies widely according to the 
geographical locations. This reflects a combination of true difference due 
to nutrition, climate, radiation, racial, ethnic or as yet unknown factors
18
. 
Also the clinical criteria used to identify the presence at the early stage of 
pseudo exfoliation, the method and thoroughness among the examiners 
should be improved. 
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Various studies conducted across the globe shows the prevalence 
of pseudo exfoliation increases with age. Mean age of presentation is 
between 60-70 years
19
. But some studies show the presentation of this 
condition in mid-adulthood too. Sex ratio reports are varying. 
Prevalence studies of pseudo exfoliation shows 3.8% in South 
India
20
, 6.45% in Pakistan
21
, 39% in Egypt , 26% in Scandinavian 
countries
22
, 5.5% in France, 20.6% in Brest
22
 and 0.4% in Chinese 
population
23
, 0% in Greenland Inuit. Also there is a greater variation in 
Spain with 0.5% in Madrid and 20% in Galicia
24
. 
Overall, it has a high prevalence among the Scandinavian countries 
and Arabian countries whereas rare among African Americans, Eskimos 
and Canadian Arctic populations
25
. 
In Iceland, study conducted by Jonasson et al reports 10% annual 
rise of pseudo exfoliation in people aged from 50 and above
26
. 
In US, Framingham Eye study revealed a rising prevalence of 0.5% 
in 52-64 yrs to 5% in 75-85 yrs
27
. 
In India Sood 
28
N.N. (1965) reported the prevalence to be 1.88%. 
Lamba and Giridhar (1984) reported as 7.4%
29
. 
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In South India Krishnadas et al (2003) reported the prevalence as 
6%
30
. 
(AHEPS) Andhra pradesh eye disease study reported prevalence of 
0.69% which increased to 3.01% in above 40 yrs and 6.28% in above 60 
yrs old
31
. 
Genetic Association: 
Pseudo exfoliation and pseudo exfoliation glaucoma demonstrates 
a strong familial aggregation, since it has got an increased relative risk on 
first degree relatives, twins, loss of heterozygosity. Also it has got a 
documented transmission through two generation pedigrees
32
. 
Tarkkanen A. (1962) suggested the possibility of a gene with three 
functions involving abnormality in aqueous drainage, pseudo exfoliation 
and degeneration of the iris pigment epithelium
33
. 
Kelvin Y.C. Lee et al studied about XFS/XFG association with 
polymorphism with R141L, G153D and intron located in the lysyloxidase 
like gene (LOXL) on chromosome 15q21
34
. 
R.R. Allinghan et al (2001) studied 6 icelandic families out of 
which atleast one affected by pseudo exfoliation syndrome and thought 
that it could be an inherited condition
35
. 
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Thorleifsson et al showed a strong association between pseudo 
exfoliation syndrome and pseudo exfoliation glaucoma with three single 
nucleotide polymorphism of LOXLI gene. (rs1048661, rs3825942)
36
. 
Multiple inheritance patterns are suggested and it includes 
autosomal dominant, autosomal recessive, X linked recessive and 
mitochondrial inheritance
32
. 
LOXLI gene located at chromosome 15q24.1 is a member of lysyl 
oxidase gene family
37
. The gene is important for the biogenesis of 
connective tissue and especially in collagen cross linking. It is found in 
cornea, iris, ciliary body, lens capsule, optic nerve, trabecular meshwork 
and zonular fibers. 
Moreover the exact mechanism which causes XFS/XFG has not 
been identified yet. Other genes associated with XFS/XFG are under 
study
37
. 
Hyperhomocysteinemia is found in PEX syndrome & PEX 
glaucoma
38
. 
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STRUCTURE OF PSEUDO EXFOLIATION MATERIAL: 
The structure of pseudo exfoliation material is a glycoprotein or 
proteoglycan. It includes a central protein core surrounded peripherally 
by complex sugars that are conjugated
39
. 
The main constituents are glycosaminoglycans and it includes 
heparin sulfate, chondroitin sulfate, dermatan sulfate and hyaluronic acid. 
The non collagenous portion includes basement membrane and elastic 
microfibril ( Elastin, Vitronectin, amyloid P, laminin, nidogen, fibrillin 1, 
TGF binding protein 1 & 2, microfibril associated glycoprotein)
39
. 
In 1973, Ringvold anlaysed the amino acid profile of pseudo 
exfoliation material
40
. 
Davanger (1978) studied the individual pseudo exfoliation material 
and its thickness. It varies according to its site. Central zone has fibrils of 
40- 60 nm in diameter. At pre-equatorial zones it is 10-40nm
41
. 
The adhesive nature of pseudo exfoliation material is due to a 
carbohydrate component Human natural Killer I
15
. 
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Theories on origin of pseudo exfoliation material: 
1. Basement Membrane theory: 
According to the basement membrane theory, the pseudo 
exfoliation is due to a disorder of extra cellular matrix. It is characterized 
by overproduction or abnormal breakdown of cell surface associated 
material but the biochemical nature is not fully understood. The advent of 
electron microscope helped us to study the pseudo exfoliation material in 
detail. The pseudo exfoliation material is produced by the anterior lens 
epithelial cells present in the pre-equatorial zone, and also by the 
basement membrane of Iris, Ciliary body and Conjunctiva.  With the help 
of transmission electron microscopy Schlotze-Schrehardt et al
42 
in 1992 
confirmed the existence of the pseudo exfoliation material in the extra 
ocular tissues. Typical pseudo exfoliation fibers were identified in lung, 
skin, kidney, liver, heart, gall bladder, blood vessels, extraocular muscle, 
connective tissue in orbit and in meninges in addition to the typical 
intraocular location. 
Harnish et al in 1981 observed that the fibrils contained a basement 
membrane proteoglycan. He made the observation based on indirect 
immunoperoxidase method
43
. 
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2. Elastic micro-fibril theory: 
Immunologically exfoliation material is related to elastic tissue. 
This observation is based on the study made by Li et al in 1989. He 
proposed that exfoliation fibers have a peripheral binding site for the 
attachment of Amyloid P which is similar to those present on normal 
elastic fibers. Also there are similarities between exfoliation material and 
the zonular micro-fibrils histochemically and antigenically.  
In 1984 Garner and Alexander proposed that oxytalan, is a 
constituent of the exfoliation fibrils. Usually oxytalan forms a micro 
fibrillar component of elastic tissue that is present in the body in areas of 
mechanical stress
44
. 
In 1987 Roh et al found mature and intermediate micro fibrils 
nearer to fibroblasts in close proximity to elastic tissue in the conjunctiva. 
In 1987 Streeten et al found histochemical similarities between 
Zonular elastic micro-fibrils and pseudo exfoliation material and a 
resemblance of the larger micro-fibrils of a ground substance to Zonular 
and other oxytalan micro-fibrils. The strong anatomic association 
between pseudo exfoliation fibres with elastosis in conjunctival 
specimens led the authors to suggest that pseudo exfoliation fibers 
themselves might be a form of elastosis, possibly resulting from abnormal 
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aggregation of components related to elastic micro-fibrils. Pseudo 
exfoliation material demonstrated elastin and elastic micro-fibril protein. 
Hence their production might reflect an abnormal stimulus or defective 
regulation of matrix synthesis
45
. 
Schlolzer – Schrehardt et al in 1998, by analyzing the pseudo 
exfoliation material under electron microscopy demonstrated it to be 
fibrillin positive fibers
46
. 
Now the widely accepted concept suggests pseudo exfoliation 
syndrome is due to pathology in the extracellular matrix and it leads to 
the production of abnormal extracellular material aggregation and 
accumulation of it. But it never decomposes. Hence pseudo exfoliation is 
considered to be systemic elastosis affecting elastic micro fibrils 
primarily
38
. 
3. Amyloid theory: 
In 1996, by examining with light and electron microscopy Repo 
L.P. Naucharinen et al made the study that the pseudo exfoliation 
material is associated with amyloid
47
. Also, miosis is associated with 
degenerative changes both in the muscular layer of iris and in stromal 
tissue. 
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Tsukahara and Matsuo observed patients with both primary 
familiar amyloidosis and exfoliation
48
. 
4. Lysozomal theory: 
In 1980 Mizuno et al found histochemical evidence of high acid 
phosphatase activity, suggesting that lysozymes are involved in the 
production of exfoliation material. Possible rupture of pigment epithelial 
cells may account for lyzosomal involvement. Proteolytic enzymes 
present in lyzosomes may facilitate granular disintegration
49
. 
In 1982 Baba studied a lipoprotein in exfoliation material and felt 
that high permeability of vessels in the anterior segment is possibly a 
result of it
50
. 
He also found the material is a sulphated glycosaminoglycan and 
suggested that abnormal glycosaminoglycan metabolism precedes the 
formation of the material. Immunohistochemical studies suggest the 
pseudo exfoliative material is made of heparin sulfate, chondroitin 
sulfate, dermatan sulfate and hyaluoronic acid. The noncollagen part 
basement membrane and elastic microfibrills includes elastin, nidogen, 
fibronectin, amyloid P, laminin, fibrillin, latent TGF bining protein 1 and 
2 and microfibrill associated glycoprotein. However the integral parts of 
molecules that are adhered to one another are still unknown. 
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Type IV collagen is restricted to a micro-fibrillar layer interposed 
between the capsular surface and typical exfoliative material. Type IV 
collagen mediates cells attachment and might be an instrumental 
adherence of exfoliation material to anterior lens capsule. Additional 
presence of elastin epitopes indicates that exfoliation material is a multi-
component, expressed in a disordered extra-celluar matrix synthesis, 
including the incorporation of the non-collagenous basement membrane 
components. Extensive labeling of exfoliation material for chondroitin 
sulphate suggestes that an over-production and abnormal production of 
glycoasaminoglycans to be one of the key changes in this disorder. 
Exfoliation material contains but does not represent true basement 
membrane material because of absence of Type IV collagen and the 
additional presence of elastin epitopes. 
5. Protein Sink Model: 
In 2008, Lee RK proposed protein sink model. According to him, 
pseudo exfoliation material is formed as a result of aberrant nucleation 
protein or due to the complex binding of protein to others and forming a 
more complex unstable protein matrix. Ultimately the formed pseudo 
exfoliation material deposits upon some intraocular structures
51
. 
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CLINICAL FEATURES: 
1.   Conjunctival changes: 
In 1976, John S. Speakman reported conjunctival pseudo 
exfoliation material is an independent source which often occurs before 
the appearance of PEX in the anterior capsular surface of the lens
52
. 
In 1987, Andrew M. Prince et al grouped the patients as “pseudo 
exfoliation suspects”. These patients are negative for pseudo exfoliation 
material on the lens but their conjunctiva showed pseudo exfoliation 
material
53
. 
By studying the inferior bulbar conjunctival biopsies under 
transmission electron microscopy, he suggested that the presence of 
pseudo exfoliation material in conjunctiva is more prevalent and there 
may be a possibility of association glaucoma in a greater proportion. 
In 2006 Haydar Erdogan et al studied the conjunctival impression 
cytology of pseudo exfoliation patients and observed the presence of tear 
film abnormalities. He suggested that the pseudo exfoliation glaucoma 
and pseudo exfoliation syndrome can cause surface changes in 
conjunctiva and thereby reduction in tear film functions.  
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Pseudo exfoliation material is also positive over conjunctival 
vessels
40
. Fluroescein angiography reveals loss of regular limbal vascular 
pattern and areas of neovascularisation and congestion of anterior ciliary 
vessels. 
2.  Corneal Changes: 
Flakes of pseudo exfoliation material and pigment accumulation 
may be found diffusely scattered over the back of cornea in the form of 
vertical spindles similar to krukenberg spindle
7
. 
In 1989 Miyanke et al studied the cornea under specular and 
electron microscopy and he postulated that the corneal endothelium is 
affected both qualitatively and quantitatively by the presence of pseudo 
exfoliation material. The corneal endothelium in pseudo exfoliation 
syndrome is unstable, predisposing to an endotheliopathy that is more 
susceptible to damage during intraocular surgery
54
.  
He observed the cell density to be decreased, hexagonality of the 
cells reduced, and an increase in the co-efficient of variation in cell size. 
Patients with pseudo exfoliation keratopathy are more vulnerable for 
diffuse corneal decomposition even with the moderate rise in intraocular 
pressure. 
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The pathogenetic causes considered are 
1. Rise in intraocular pressure. 
2. Hypoperfusion of anterior segment due to relative ischaemia. 
3. Extracelluar matrix deposition causes membrane destabilization 
especially between endothelial layer and descement membrane 
and the cells loses its polarity. 
4. Impaired Blood-aqueous barrier results in Iridopathy and 
alteration in aqueous humour dynamics
27
. 
In 1993, Schlotzer-Schrehardt and Naumann remarked that the 
pseudo exfoliation material is produced by the endothelial cells that are 
focally degenerated
55
. 
In 1994, Bourne et al studied a progressive decline in endothelial 
cell density after cataract surgery. This is due to the phenomenon that the 
human cell continues to transform years after cataract surgery even 
though the damaged area during lens extraction is healed and recovered
56
. 
In 1998 Christoper et al studied the corneal endothelial cell 
changes in pseudo exfoliation syndrome after cataract surgery. He 
compared the corneal endothelial cells of normal patients with the pseudo 
exfoliation patients post operatively after the cataract surgery
57
. 
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He concluded that both the groups presented with similar mean 
endothelial cell reduction. However in the presence of any corneal guttata 
or glaucoma preoperatively, it adds to the risk of corneal endothelial cell 
loss. The appearance of guttata in corneal endotheliopathy of pseudo 
exfoliation patients differ from those seen in Fuchs endothelial corneal 
dystrophy, pseudophakic or Aphakic bullous keratopathy. The corneal 
guttata in pseudo exfoliation endotheliopathy are less in number and more 
diffusely distributed along with melanin dispersion and iris atrophic 
changes at the pupillary margin
57
. 
He also added the anterior chamber manipulation in pseudo 
exfoliation patients with posterior capsular rupture and anterior 
vitrectomy increases the chance of endothelial decomposition
57
. 
3. Lens and Zonules 
5, 6, 7, 58
: 
The most consistent and the most diagnostic finding is the 
deposition of white flakes on the anterior surface of the lens in a peculiar 
pattern. On dilating the pupil with a mydriatic “3-ring or target like or eye 
bull” sign is seen on the anterior lens surface. 
The central disc is relatively homogenous corresponds roughly to 
the diameter of un-dilated pupil. It is a translucent white sheet lying on 
the anterior pole of the lens capsule. The size varies between 1.5-3 mm. 
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The central disc is absent in 20% of pseudo exfoliation cases or more. 
The central part is usually overlooked but with careful examination after 
dilation, subtle changes can be noted. 
The intermediate zone is clear probably due to the contact with the 
moving iris that rubs off the material. 
The peripheral zone is the most consistent finding and it is always 
present. It is granular with radial striations and has layers. Axially it is 
bounded by curled edges and partly by tongue shaped projections. 
Equatorially it extends as a granular tongue shaped projection which 
merges into the normal capsule before reaching the anterior zone of 
insertion of the zonular fibres. The peripheral band may be situated close 
to the equator in some eyes and more axially in others. The granularity is 
because of undisturbed accumulation of pseudo exfoliation material. 
A precursor of pseudo exfoliation material is the pre capsular film 
initially deposited diffusely on the lens surface. The pre capsular film is 
homogenous and has a “ground-glass or matte” appearance. The ultra 
structure study of pre capsular layer shows micro-fibrils similar to pseudo 
exfoliation material. It is best visualized by placing the slit beam at 
45Degree to the axis of observation reducing the light source and 
focusing temporarily 2-3mm from the centre of the lens. 
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Clinical classification of Exfoliation  syndrome based on 
morphological alterations of the anterior lens capsule 
59:
 
Preclinical stage: Usually, clinically invisible 
Suspected pseudo exfoliation syndrome 
i. Early suspect (Electron-microscopy): Precapsular layer. 
ii. Masked/Suspected pseudo exfoliation syndrome:  Posterior 
synechiae without any obvious cause. 
iii. Mini-Exfoliation syndrome: Focal defects start supero-nasally. 
iv. Classic exfoliation syndrome: Late stage. 
Several authors studied the 3 zones in the anterior surface of 
capsule and noticed peripheral band is always present. 
In 1987, Ruotsalainen & Tarkkanen reported that there is no 
variation in thickness of capsule between the pseudo exfoliation patients 
and non-PEX cataractous lenses
60
. 
Several studies done by Hiller et al in 1982, Hirvela et al in 1995, 
Pushka and Tarkkanen in 2001 reported a higher incidence of nuclear 
cataract in PEX eyes
61
. 
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However Reykjavik Eye study made by Arnarsson et al in 2002 
found no relationship between nuclear sclerosis & PEX
62
. 
Pseudo exfoliation material deposited over the zonules produce 
weakening of zonules and zonular instability leading on to phacodonesis 
and lens subluxation
5
. 
Zonular instability is produced by the following mechanisms: 
1. At first, the pseudo exfoliation material produced by the pre-
equatorial lens epithelium proliferates through the capsular 
surface and causes disruption of zonular lamella at its insertion 
into the anterior lens capsule. 
2. Secondly, the zonular attachments are separated from their origin 
and anchored in the basement membrane of nonpigmented ciliary 
epithelium. 
3. At last, the proteolytic enzymes released from the pseudo 
exfoliation material disintegrate the zonules. 
Thus, leads on to zonular instability, phacodonesis and inferior 
dislocation of lens
5
. 
Preoperative evaluation of anterior chamber depth serves as a 
prognostic indicator for assessing zonular weakness. 
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In 1994 Ritch proposed loosening of zonules causes dislocation of 
lens anteriorly with an angle closure attack
63
. 
4. Ciliary body: 
Mizuno and Muroi in 1979 examined ciliary processes clinically. 
Cycloscopic examination revealed deposition of exfoliative material in 
the Zonules and Ciliary processes. Gonioscopic examination through a 
patent basal iridectomy also showed deposition of exfoliative material 
over ciliary processes. 
These changes are detected early before the appearance of pseudo 
exfoliation material on the anterior surface of the lens capsule.
64
 
5. Iris and Pupil: 
Pseudo exfoliation material is seen as grey-white flakes at the 
pupillary margin. The pupillary ruff loses its pigments and has a moth-
eaten appearance. The pigments are released into anterior chamber and 
cause transillumination defects in iris
11
. 
In 1971 Laatikaanen
65
, in 1983 Brooks & Gillies
66
 studied the iris 
angiography in pseudo exfoliation patients and suggested that it shows 
iris hyper perfusion, peripupillary leakage and neovascularisation. 
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In 1981 Ringvold & Davanger reported that the vascular 
abnormalities or the production of abnormal extracellular matrix causes 
tissue hypoxia
67
. 
Repo et al in 1993 conversely said hypoxia may be the primary 
event causing production of pseudoexfoliation material
68
. 
In 1993 Droslum et al and Asano et al in 1995 proposed Iris 
hypoxia can lead to atrophy of iris pigment epithelium, Stroma and 
muscles leading on to poor response to mydriatics. Further, Mardin et al 
in 2001 suggested the formation of posterior synechiae also restrict the 
dilation of pupil
69
. 
The breakage in blood aqueous barrier predisposes to synechial 
formation between anterior lens capsule and the pigment epithelium of 
iris. 
6. Angle Characteristics
5
: 
Gonioscopic findings shows increased meshwork pigmentation 
which is distributed unevenly. In addition to pigmentation it also has 
deposition of pseudo exfoliation material. 
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Apart from trabecular meshwork, pigmentation is also seen in 
schwalbe line and it is known as Sampolesi line. In eyes with 
asymmetrical pigmentation, the eye with more pigmentation is more 
prone for glaucoma. Angle studies on the basis of peripheral anterior 
synechiae shows 9% to 18% of the angles are occludable and 14% are 
closed angles. 
Trabecular meshwork, Schlemm canal, collector channels serve as 
site for active exfoliation material production and the intertrabecular 
spaces remain as the space for deposition of the formed material. 
Accumulation of the exfoliation material leads to juxtacanalicular 
meshwork swelling and the architecture of Schlemm canal is lost in 
advanced cases. Very rarely a pretrabecular sheet of abnormal 
extracelluar matrix is formed by the proliferation and migration of 
corneal endothelial cells that covers the uveal meshwork. 
In 2000 Vesti and Kivela mentioned the relationship between 
pseudo exfoliation syndrome and pseudo exfoliation glaucoma
70
. 
In a study by Drolsum et al, he found 48.9% of eyes with PEX had 
glaucoma but only 6.8% in eyes without PEX.  
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7. VITREOUS: 
Since hyaluronic acid and pseudo exfoliation material both are acid 
mucopolysaccharides, vitreous changes do commonly occur. Change in 
aqueous composition lead to derangement of hyalocyte metabolism 
resulting in impaired production of hyaluronic acid and liquefaction. 
PSEUDO EXFOLIATION AND GLAUCOMA
5
: 
Eyes with pseudo exfoliation are at risk for glaucoma. The early 
manifest glaucoma trial shows eyes with ocular hypertension and 
pseudoexfoliation are at two times higher risk for the development of 
glaucoma. 
Apart from open angle glaucoma, pseudo exfoliation syndrome 
also present with angle closure in small number of cases. Also, the 
patients present with acute rise in intraocular pressure with open angles. 
OPEN ANGLE GLAUCOMA
5
: 
All the patients with pseudo exfoliation syndrome may not end up 
with glaucoma at the same time glaucoma can occur in both eyes in 
patients having unilateral pseudo exfoliation. 
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This led to the thought of similar mechanism of aqueous outflow 
obstruction in both chronic open angle glaucoma and pseudo exfoliation 
glaucoma. 
Eyes with pseudo exfoliation are at higher risk of glaucoma, hence 
a causal relationship between the abnormal exfoliation material and the 
rise in IOP is established. Further the pseudoexfoliative glaucoma 
responds poorly to antiglaucoma medications and topical corticosteroids. 
Hence the possibility of different mechanism causing glaucoma in PEX is 
established
5
. 
Local production of exfoliative material from trabecular 
meshwork, its endothelial cell damage and deposition play a role in rise 
in intraocular pressure. It is also found that optic neuropathy sets faster in 
eyes with pseudo exfoliation glaucoma. 
This suggests the presence of an intrinsic vulnerability of the optic 
nerve for the damage to occur. 
Even though the disc area and the morphometric features of optic 
nerve head remains the same, glaucomatous neuroretinal rim involvement 
is sectoral in chronic open angle glaucoma whereas more diffuse in 
pseudo exfoliation glaucoma
5
. 
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Also, the Immuno electronmicroscopic studies show the 
occurrence of elastosis in laminacribrosa suggesting the role of 
LOXL1gene
5
. 
ANGLE CLOSURE GLAUCOMA: 
In 1988 Gillies W.E. studied 139 cases of pseudo exfoliation 
syndrome with acute glaucoma.  Among these, 86 presented with open 
angle glaucoma, 21 with neovascular glaucoma and 18 with acute angle 
closure glaucoma. 
The mechanisms causing angle closure glaucoma are Zonular 
weakness leading to anterior dislocation of lens, thickened lens due to 
cataract formation, posterior synechiae leading onto increased 
adhesiveness of iris to lens, degeneration of sphincter muscle and iris 
rigidity. The anterior chamber depth in angle closure glaucoma is less 
than 2.2mm
5
. 
SYSTEMIC MANIFESTATION: 
Ultra structural studies, conducted on autopsied specimens suggest 
pseudo exfoliation syndrome is a multisystem disorder. Pseudo 
exfoliation material is found in skin, lungs, gallbladder, liver, 
myocardium, kidney, bladder, cerebral meninges. In eyes it is also found 
 
 
Page | 29  
 
in extra ocular muscles, orbital septa, posterior ciliary arteries, vortex 
veins and central retinal vessels. An association of PEX with abdominal 
aorta aneurysms is studied extensively. The staining of the material in 
these organs is similar to the staining pattern found in eye. These findings 
are consistent with an aberrant connective tissue metabolism throughout 
the body
5
. 
CATARACT SURGERY IN PSEUDOEXFOLIATION 
SYNDROME: 
Patients with pseudo exfoliation syndrome are more prone for 
complications during and after surgery. Cataract surgery in pseudo 
exfoliation syndrome is a challenging surgery because of the two very 
important risk factors. 
1. Poor pupillary dilatation, due to ischaemia of iris and infiltration 
of exfoliative material into iris which produces obstruction to 
dilatation mechanically 
2. Zonular weakness which is increased in old age, glaucoma, hard 
cataract 
Careful examination of corneal endothelium is mandatory in 
advanced cases of pseudo exfoliation. A shallow anterior chamber depth 
should arouse the suspicion of zonular instability
71
. 
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Ultrasonographic biomicroscopy is also very helpful to look for 
significant zonular weakness and to detect the presence of stretched 
zonules. 
Eyes with pseudo exfoliation are at high risk for posterior capsular 
rupture, zonular dialysis, intraocular bleeding and vitreous loss intra 
operatively. The presence of zonular instability increases the risk for 
dislocation of lens, zonular dialysis and vitreous loss to ten times. 
Patients with pseudo exfoliation are at greater risk of developing a 
rise in intraocular pressure and inflammation in the immediate post-
operative period. Pigment deposition in IOL is also seen. Decenteration 
of intraocular lens is more common even though the lens is placed in the 
bag due to the malposition of entire bag. Capsular contraction syndrome, 
if exaggerated, can also lead to intraocular dislocation. Secondary 
cataract is more common because of aggravated blood-aqueous barrier 
breakdown
72
. 
In 1987 Skuta G.L, Parish R.K et al observed an increased 
incidence of zonular dialysis during cataract surgery in patients with 
pseudo exfoliation syndrome. They also attributed an asymmetrical 
anterior chamber depth, preoperative phacodonesis and excessive 
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movement of lens during capsulotomy should alert the suspicion of 
zonular dialysis
73
. 
Various studies made by Goder and Rechlin in 1988, Puska et al in 
2000, Inazumi et al in 2002, Guo et al in 2006 regarding the use of more 
sophisticated procedures like scheimpflug photography, ultrasound 
biomicroscopy observed that they are very helpful in diagnosing zonular 
weakness. 
In 1989 Naumann G.O, Kuchle M, Schonherr U noted increase in 
vitreous loss to seven fold in patients with pseudo exfoliation syndrome 
undergoing cataract surgery
74
. 
In 1999 Wang L, Yamasita R et al observed the eyes with pseudo 
exfoliation syndrome with specular microscopy and quantified the 
aqueous flare with laser flare cell meter. Corneal endothelial cell density 
is significantly reduced in eyes with pseudo exfoliation syndrome and an 
inverse correction was shown with flare. An association of decrease in 
corneal endothelial cells and disruption of blood-aqueous barrier is 
made
75
. 
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In 1997 Kuchle M, Naumann H et al conducted a study and 
presented that the patients with pseudo exfoliation syndrome are 
frequently associated with impaired blood aqueous barrier. This is 
responsible for having higher frequency of after cataract 
postoperatively
76
. 
In 1993, Lumme P. Lattikaanen L studied 351 patients with pseudo 
exfoliation undergoing cataract surgery. He observed that the prevalence 
of pseudo exfoliation is more in patients aged greater than 70 years. He 
also mentioned that the intraoperative risk is more, either directly due to 
rupture of zonules or indirectly due to poor dilation of pupil. The vitreous 
loss increased in these patients to four fold and the need to use an anterior 
chamber intraocular lens to tenfold
77
. 
In 1988, Hovding reported 17.9% capsule or zonular breaks in 
pseudo exfoliation patients who underwent extra capsular cataract 
extraction whereas it is only 5.6% in non- pseudo exfoliation eyes. 
In 1998 Scrolloli et al emphasized that PEX patients develop 
intraoperative complications five times more than non-PEX patients
78
. 
In 2000, Morena et al reported that poor dilatation, irido-
phacodonesis and presence of glaucoma are associated with posterior 
capsular rupture during cataract surgery.
79
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In 2000, Kuchle et al noted that an anterior chamber depth of less 
than 2.5mm pre-operatively indicates zonular instability and should alert 
the surgeon of intraoperative complications
80
. 
   In 1994, Freyler H. Radax U compared extra capsular cataract 
surgery with phacoemulsification. He noted miosis and phacodonesis 
were the two important risk factors. Phacoemulsification was noted to be 
superior than extra capsular cataract surgery and had significantly lesser 
complications
81
. 
In 1966 Stanila A studied the intraoperative and post-operative 
complications in pseudo exfoliation patients undergoing cataract surgery. 
He noted poor pupillary dilatation, posterior capsular tears, loss of 
vitreous and rise in post-operative intraocular pressure and high chance of 
posterior capsular opacification
82
. 
In 2002 Vickie Lee and Anthony Maloof emphasized that a CTR 
stabilizes the capsular bag by redistributing forces. Thereby CTR 
produces tautness of bag which gives a counter traction while operating. 
CTR is useful in zonular dialysis of less than 5 clock hours. CTR should 
be inserted at right time during the surgery to avoid the intraoperative 
complications,   usually after doing a capsulorhexis but before 
hydrodissection
83
. 
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In 2004 Albert Garland MD et al studied the pathophysiological 
alterations associated with pseudo exfoliation, its intraoperative 
consequences and the considerations for surgical and intraocular lens 
modifications. They noted the poor pupillary dilatation to be an important 
risk factor and suggested, it can be managed by using high viscosity 
viscoelastic agents and iris hooks. Sphincterotomy, the most widely 
performed technique even now days was cautioned since it could cause a 
persistent dilatation and hence cosmetically not accepted. They suggested 
that the usage of hydrophobic acrylic and silicon lens lowers the rate of 
posterior capsular opacification
84
. 
In 2008 Howard Fine reported “CTR can convert a high risk case 
into a routine case”. The principle behind the usage of CTR is that it has 
got a ring diameter larger than capsular diameter and the centrifugal force 
created is distributed equally throughout the zonular apparatus 
circumferentially. In case of advanced zonular dialysis more than 5 clock 
hours with overt subluxation capsular tension segments can be used. It is 
120 degrees, a partial CTR. A very loose bag can be supported with two 
CTS
85
. 
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MANAGEMENT OF CATARACT SURGERY IN PSEUDO 
EXFOLIATION SYNDROME: 
Cataract surgery in patients with pseudo exfoliation requires special 
attention 
1. Careful and detailed pre-operative evaluation. 
2. A well planned surgical strategy. 
3. Closer follow-up postoperatively. 
1. Detailed preoperative evaluation: 
To avoid intraoperative surprises and to choose a surgical plan, a detailed 
preoperative evaluation is mandatory.  It includes 
 Check the visual acquity and find if there is any discrepancy 
between the lens changes and visual acquity. 
 Assess for the presence of potential glaucoma. 
 Under slit lamp look for the direct instability signs such as 
Phacodonesis, Iridodonesis, Subluxation of lens 
 Also look for indirect signs of instability such as any significant 
change in the depth of the anterior chamber (shallow, deep or 
irregular) 
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 Do a dilatation test and check the status of the optic nerve 
 In advanced cases also a specular microscopy to study the corneal 
endothelial cells. 
2. Well Planned Surgical Strategy: 
 Each eye is different and based on it the surgical considerations 
should be modified. 
a. Incision: 
 A temporal approach is more advisable, since the zonular 
instability starts mostly in the superior area
71
. 
In phacoemulsification, a clear corneal incision at the temporal periphery 
is usually preferred for the following reasons 
 This approach saves the superior location for filtration surgery 
in future, if needed 
 Cornea being an avascular plane less chance of fibrinoid 
reaction in anterior chamber
86
. 
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b. Ophthalmic Viscosurgical Devices: 
The OVD we use should serve two important purposes 
 Stay for a longer time 
 To protect the corneal endothelium 
Also, care should be taken not to over pressurize the chamber since 
it may lead on to further damage of the zonules. 
 To address the above requirements, soft shell technique, which 
utilizes the usage of two OVDs, a cohesive and a dispersive will serve as 
a good option
71
.  
c. Maximum pupillary dilatation: 
i. PHARMACOLOGICAL METHODS: 
The use of pharmacological methods such as Adrenaline or 
Phenylephrine intracamerally is of little or no use 
ii. NON-PROSTHETIC METHODS: 
It includes the usage of  
 Viscomydriasis 
 Iris stretching manually 
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 Iris microsphincterotomies 
 Sector iridectorny 
The advantage of non prosthetic methods is less instrumentation 
but it makes the iris atonic after manipulation and it is very difficult to do 
phacosurgery
83
. 
iii. PROSTHETIC METHODS: 
A wide range of rings and dilators are available which can be used 
according to the preference of the operating surgeons. It includes 
1) Iris hooks 
2) Malyugin ring 
3) Beehler pupil dilator 
4) Dilation ring 
5) Y – hooks 
6) Special dilating forceps 
 The prosthetic devices confer more effective iris control. Flexible 
iris hooks are used initially for enlarging the pupil and then for stabilizing 
the anterior capsule thereby it prevents the posterior subluxation of lens
83
. 
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Beehler pupil dilator can be used for small pupils. It stretches upto 
6-7mm at the cost of microsphincterotornies around the pupillary margin 
circumferentially
86
. 
However pupil stretched by this manner retains a good cosmetic 
appearance. Sometimes it may require miotics to prevent synechias to the 
capsulorhexis margin. 
In 2004, Akman et al compared Y- hooks, pupil dilator polymethyl 
methacrylate rings, iris retractor hooks, and special dilating forceps. He 
found all were equally promising. He noted iris retractor hooks and 
PMMA pupil dilating rings were time consuming. Of all, dilation ring 
proved to be the most promising since it caused least trauma. 
All the pupillary maneuvers produce an altered blood aqueous 
barrier, hence as long as we can operate safely; it is not advisable to alter 
the pupil. 
d. Anterior Capsulotomy: 
Previously used anterior capsulotomy techniques such as can-
opener or envelope techniques are more risky since the torn capsule can 
readily run peripherally and lead on to posterior capsule rupture and 
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vitreous loss. Nowadays, performing continuous curvilinear 
capsulorhexis has become a routine
87
. 
In a study conducted by Shastri and Vasavada in 2001, it was 
found that the CCC can be performed in PEX eyes in a similar fashion as 
in non PEX eyes. 
Capsular fibrosis, its fragility and zonular weakness makes the 
initiation and completion of the capsulorhexis very difficult. The usage of 
dyes like Trypan blue and Indocyanine green helps to stain the capsule 
well and allows better visualization. While staining “Sweeping 
technique” is recommended
83
. Here we inject a few drop of dye (trypan 
blue) under ophthalmic viscosurgical devices and this is spreaded with a 
spatula over the anterior capsule. This technique prevents the dye from 
entering into the vitreous cavity through an impaired area
71
. 
A successful capsulorhexis requires the following approach. 
1. Avoid over inflation of the anterior chamber with viscoelastics 
which may further unzip the zonular weakness. 
2. Assess the zonular weakness gently by putting a blunt instrument 
over the lens and rock it to & fro smoothly. 
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3. An excessive movement of the lens during CCC should arouse 
the suspicion of zonular weakness. 
4. Use a sharp tip to start with CCC, since already the weak zonules 
offer a poor resistance to perform CCC 
5. Look for any wrinkling of anterior capsule while performing 
CCC. The wrinkles indicate the presence of loose zonules. 
Multiple grasps will help in completing the CCC successfully
87
. 
CCC should not be too small or too large. If too small, it adds 
further stress to weak zonules and if too large, zonular attachment can get 
engaged resulting in PCR and vitreous loss. Ideal CCC should be 5.5-
6mm. Atleast 6mm since the large capsulorhexis leaves back less lens 
epithelial cells
86
. 
If unable to do an ideal capsulorhexis, perform it at the end of 
surgery or do Nd-YAG laser relaxing capsulotomy within the first month 
(immediate post-operative period). 
Two handed capsulotomy technique described by Neuhann is an 
excellent alternative. It makes use of tangential force. One hand holds the 
flap with a forceps through main incision and exerts a slight backward 
traction whereas the other hand advances the torn edge tangentially. 
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This is more important since the small capsulorhexis will harbor a 
large amount of lens epithelial cells which further undergoes metaplasia 
leading onto capsular fibrosis post operatively
71
. 
e. Hydrodissection and hydrodelineation 
 Hydrodissection, isolates cortex from the capsule and forms one of 
the mandatory step. The advantage is it reduces the chance of zonular 
damage. 
Ideal Hydrodissection should be done in the following procedure: 
1. It is important to remove some viscoelastic substances before 
performing hydrodissection. This simple idea minimizes the 
excessive pressure in anterior chamber. It is done by pressing the 
lowerlip of the incision with the cannula. 
2. As mentioned by Vasavada, Hydrodissection should be 
performed in all quadrants (3 or 4 areas), since this would help in 
redistributing the stress throughout the bag. 
3. Hydrodissection is not complete unless we see the BSS coming 
out of the capsular bag. 
4. Performing hydrodelineation is very useful since it produces an 
epinuclear shell which acts as an additional safeguard
71
. 
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f. Extraction of lens nucleus/phacoemulsification 
A study conducted by Hyams et al in 2005 stated, the rate of 
intraoperative complications is much lower in phacoemulsification than 
in ECCE. This is confirmed by others [Dosso et al 1997, Shastri & 
Vasavada 2001, Nagashima 2004] 
Increased force needed for extraction of lens nucleus through a 
relatively miotic pupil raises the intraoperative complications during 
ECCE, whereas in phacoemulsification gentle manipulation is done
87
. 
g. Management of zonular weakness 
Capsular Ring: 
This is a very useful device and helps in distributing the traction 
equally in the presence of loose zonules (Hara et al 1991; Hasanee et al 
2006). 
Also it should be noted that CTR will not always prevent an 
increase in subluxation.  Similarly neither it prevents postoperative 
capsular contraction nor in the bag dislocation of IOL. 
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Ideal time of CTR implantation during surgery should be 
individualized.  Some surgeons prefer it to use immediately after 
hydrodissection whereas some just after removing the epinucleus and 
cortical remnants
71
. 
In 2001 Bayraktar, et al reported that the usage of CTR before 
phacoemulification minimizes the risk of zonular dialysis in PEX eyes. 
He also added if CTR is correctly placed just beneath the capsule it 
avoids entrapment of cortical material by the CTR. 
In 2005 Ahmed, et al reported early implantation of CTR is 
hazardous. It can increase the capsular torque significantly and lead on to 
displacement. 
However CTR can be implanted immediately when there is an 
increased zonular weakness independent of the phase of surgery. 
Various signs that arouse the suspicion of zonular weakness are 
 Difficulty in rotating the nucleus or fragments freely. 
 Localisation of the subluxated area. 
 Ovalisation. 
 More flaccidity of the rhexis edges. 
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The important technique in implanting CTR is, it should be started 
in the direction of maximum instability. CTR can be used in less than five 
clock hours of zonular weakness
71
. 
In greater degrees of zonular weakness a new ring is designed with 
an eyelet for sclera fixation or else can use capsular retractors to hold the 
capsule
83
. 
h. Irrigation & aspiration: 
Abundant cortex and poor pupil dilation possess a high stress over 
zonules. Aspiration with tangential movements lessens the zonular stress. 
If, any areas of zonular dehiscence the cortical material should be 
removed by striping tangentially towards the dehiscence
71
. 
i. Anterior capsular polishing 
It is done to reduce the anterior capsular contraction 
postoperatively. The central 6mm of anterior capsule is removed where 
there are more lens epithelial cells. 
j. Choice of intraocular lens: 
To have a greater biocompatibility, lens with following features 
should be used 
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1. Hydrophobic acrylic optic with 3 piece PMMA to minimize the 
potential inflammation. 
2. Square edged to minimize the possibility of posterior capsular 
opacification. 
3. Use heparin coated IOL’s. 
4. Avoid plate haptic foldable silicone IOL’s. 
5. Evaluate lens implant stability by Bounce test. This is done by 
voluntarily decentering and releasing the IOL.  It should fall back 
to its original position (spontaneous recenteration).If not, remove, 
reposition and reevaluate. 
 In occurrence of PCR, lens can be placed in the ciliary sulcus if 
there is an adequate capsular support. 
 In cases if there is no capsule, Iris-claw IOL or Scleral fixated IOL 
can be used
71
, 
87
. 
3. Follow-up: 
 Post operative complications have an insidious onset; hence a 
careful and regular follow-up is mandatory
71
. 
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Early Complications: 
a) Postoperative Inflammation: 
Due to blood-aqueous barrier breakdown postoperative 
inflammation is common and it depends on the iris trauma. 
Earlier, the inflammatory response, posterior synechiae was 
relatively high in PEX patients. 
Now phacoemulsification being a standard procedure causes less 
iris trauma and hence post operative inflammation has come down
87
. 
b) Pressure Spikes: 
Various studies conducted by various authors showed a rise in IOP 
postoperatively. 
Washing out the viscoelastics thoroughly at the end of surgery is of 
prime importance to reduce the possibility of rise in IOP. 
A prophylactic treatment can be given to high-risk cases to combat 
the rise in IOP postoperatively. 
 
 
 
 
Page | 48  
 
In 1987 Handa, et al found a reduction in IOP in some PEXG 
patients. In 2003 Shingleton, et al argued the reason for reduction in IOP 
in some PEX patients is due to washout of pseudo exfoliation deposits 
thereby improving the outflow. 
 Recently, now in 2014 V. Tao Tran proved washout of pseudo 
exfoliation material combined with cataract surgery lowers the IOP in 
PEX eyes
87
. 
C) Corneal Edema: 
 The presence of corneal guttata preoperatively raises the 
endothelial cell loss postoperatively resulting in corneal edema and 
corneal decompensation
57
.  
D) Capsular contraction sundrome: 
 It occurs within a month. An imbalance between the peripheral 
weakness and a central contractile force causes a capsular fibrosis. This 
can be avoided by performing  
 Optimal anterior rhexis or secondary capsulorhexis. 
 Vacuuming the undersurface of anterior capsule intra 
operatively prior to IOL implantation. 
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 Using rigid PMMA haptics. 
Capsular fibrosis leads on to displacement of IOL and zonular 
dehiscence
71, 86
. 
.
 
Late complications: 
1. Spontaneous dislocation of lens: 
 This is due to progressive zonulopathy. It takes at least 7 years. The 
capsular ring does not prevent it and it is mandatory to do a sclera 
fixation of IOL. 
2. Posterior capsular opacification 
The occurrence is high in patients with 
 Post operative inflammation 
 Incomplete AC wash, with cortical remnants 
 Impairment of blood-aqueous barrier 
 Hypoxia 
 Zonular weakness 
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 Nishi, et al in 2004, Dewey in 2006 reported that there is a 
significant reduction in posterior capsular opacification due to 
improvement in IOL designs and surgical techniques
86
. 
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AIM OF THE STUDY 
 
1. To study the risk factors leading to intra-operative complication 
in patients with pseudo exfoliation undergoing cataract surgery. 
2. To determine the intra-operative and postoperative complications 
in patients with pseudo exfoliation syndrome undergoing cataract 
surgery. 
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RESEARCH METHODOLOGY 
  
STUDY DESIGN: 
A hospital based cross-sectional study. 
SETTING: 
Study was done at Department of Ophthalmology, Coimbatore         
Medical College Hospital, Coimbatore. 
DURATION OF STUDY: 
From August 2013 to July 2014 
STUDY POPULATION: 
 Patients who attended the Ophthalmology OPD and inpatients with 
pseudo exfoliation syndrome and cataract were included in the study 
based on selection criteria. About 50 patients were included in the study. 
INCLUSION CRITERIA: 
 Pre-senile and senile cataract patients with pseudo exfoliation in 
one or both the eyes were included in the study. 
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EXCLUSION CRITERIA: 
The study excludes 
1. All patients with glaucoma including known pseudo exfoliation 
glaucoma and increased IOP 
2. Developmental, Juvenile, Traumatic cataract 
3. Previous h/o trauma 
4. Previous h/o intraocular surgeries 
5. Systemic conditions predisposing to subluxation of Lens 
6. Uveitis 
7. Posterior segment pathology 
STUDY METHODS: 
 Verbal consent was obtained from the patients selected for study. 
Data collected using structured questionnaire which comprises socio 
demographic characteristics like age, sex, occupation & detailed history. 
Clinical Examination includes  
1. Visual Acuity testing for distant and near objects by using 
snellen’s chart for distant and near respectively 
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2. Refraction 
3. External ocular examination 
4. Slit Lamp Bio microscopy 
To look for the following evidences:  
• Presence of pseudoexfoliation along the pupillary margin, iris 
surface and anterior surface of the lens 
• Morphopathological changes in cornea 
• Breakdown in blood aqueous barrier 
• Irregular/ shallow anterior chamber depth 
• Pigment dispersion in anterior chamber 
• Iridodonesis 
• Phacodonesis with Subluxation/Dislocation of lens 
• Posterior synechiae 
• Measurement of pupillary size before and after dilatation 
• Pupillary reaction 
• Type of cataract (nuclear, posterior subcapsular cataract, 
cortical Cataract) 
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Van Herick method for anterior chamber angle assessment
7
 
PACD 
proportion 
to CT 
Grade Description Comment 
> 1 4 
Peripheral anterior 
chamber space equal to full 
corneal thickness or larger. 
Wide open 
1/4-1/2 3 
Space between one-fourth 
and one-half corneal 
thickness. 
Incapable of closure 
1/4 2 
Space equal to one-fourth 
corneal thickness 
Should be 
gonioscoped 
<1/4 1 
Space less than one-fourth 
corneal thickness 
Gonioscopy shows 
dangerously 
narrowed angle. 
                 
1. Intra ocular pressure measurement using Goldmann Applanation 
tonometry. 
2. Gonioscopy with the help of Goldmann single mirror. The patients 
with pseudoexfoliation were carefully evaluated and graded 
according to their findings. 
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Grading of Angle width (Shaffer’s grading)
7
: 
 
Grading of Trabecular meshwork pigmentation 
Grade 0 NIL 
Grade 1 Faint 
Grade 2 Average 
Grade 3 Moderate 
Grade 4 Heavy 
Grade 
Angle width  
(degrees) 
Configuration 
Structure seen on 
gonioscopy 
Chance of 
closure 
4 35-45 Wide open 
From Schwalbe’s 
line to Ciliary body 
Nil 
3 25-35 Open 
From Schwalbe’s 
line to Scleral spur 
Nil 
2 20 
Moderately 
narrow 
From Schwalbe’s 
line to Trabecular 
meshwork 
Possible 
1 10 Very narrow 
Schwalbe’s line 
only 
High 
0 0 Closed 
None of the 
structures are 
visible 
Closed 
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Patients were noted for the presence of sampolesi’s line. 
1. Fundus Examination 
2. Pupillary measurement before and after full dilatation 
3. Keratometry 
4. A-scan and power calculation for intra ocular lens 
5. Lacrimal patency test 
6. Urine sample for sugar 
7. Random Blood sugar 
8. ECG 
9. If Diabetic, Fasting and post prandial blood sugar and 
Diabetologist opinion regarding fitness for cataract surgery 
10.  If Hypertensive, Pysician opinion regarding fitness for cataract 
surgey 
11.  If Cardiac patient, ECG, and Cardiologist opinion regarding 
fitness for cataract surgery 
12.  Last but not least rule out any septic foci elsewhere in the body 
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PRE-OPERATIVE CARE: 
 Prior to the day of surgery, Injection TT 0.5ml, Test dose of 
Lignocaine was given. On the day of surgery, pupils were dilated with 
Tropicamide 0.8% and phenylephrine 5%. One drop for every 15 minutes 
one hour before surgery till the pupil was adequately dilated. To prevent 
the intra operative constriction of pupil non steroidal anti-inflammatory 
drugs like Flurbiprofen 0.03% was instilled one drop every 15 min. A 
written consent was obtained from the patient for cataract surgery. 
LOCAL ANAESTHESIA: 
 A peribulbar block was given to obtain intra ocular anaesthesia and 
analgesia. The constituents of peribulbar block include 2% lignocaine, 
0.75% Bupivacaine, Adrenaline 1:200,000, Hyaluronidase 5mg/ml. A 25 
guage disposable needle attached to a 5 ml syringe was used. The patient 
was made to lie down in supine position and asked to look steadily 
straight ahead. The needle was inserted at the junction of middle two-
thirds and lateral one-third of lower eye lid along the floor of the orbit. 
The syringe was withdrawn and checked for any inadvertent entry into 
blood vessel. Second injection was given just inferomedial to supraorbital 
notch. One drop of 5% povidone drop was instilled into the conjunctival 
sac. 
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SURGICAL TECHNIQUE:  
1.   The eye to be operated was painted with povidone and 
draped under strict aseptic precautions 
2.   Universal eye speculum was applied 
3.   Superior rectus (bridle suture) was applied to fix the eye in 
down gaze 
4.   A fornix based conjunctival flap was made 
5.   Underlying Tenon’s capsule was cut 
6.   Perfect haemostasis achieved by applying gentle and 
adequate cautery 
7.   A 6-7mm self sealing sclera-corneal tunnel incision made 
2mm from limbus using an 11-blade. Thickness should be ½ of 
scleral thickness 
8.   With the crescent blade scleral lamellae was dissected and 
tunnel created 
9.   Tunnel extended into cornea for 2mm 
10.  A 2.8mm Keratome was used to create an internal opening 
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11.  A side port was created 90 degree away from the tunnel 
12.  Air was injected to form the anterior chamber followed by 
tryphan blue 
13.  Tryphan blue stains the anterior capsule and after a few seconds 
it was washed away 
14.  Anterior chamber was filled with viscoelastic (2% hydroxyl 
propyl methyl cellulose) 
15.  Ideal size of Capsulorhexis of about 6mm was made using 27 
gauge needles 
16.  Using 3.2mm extending knife the internal lip of tunnel was 
extended 
17.  Careful hydrodissection was done to separate cortico-nuclear 
mass from posterior capsule 
18.  If, the pupil was not adequately dilated a manual stretching or 
sphincterotomy can be done depending on the decision of 
operating surgeon 
19.  Synechiolysis can be done if present 
20.  Nucleus was removed 
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21.  Cortical material was removed by irrigation and aspiration 
22.  In case of posterior capsular rent, the integrity of the capsular 
bag was assessed to place the IOL 
23.  In case of vitreous loss, anterior vitrectomy was done 
24.  If the posterior capsule was intact IOL was placed inside the bag 
25.  The remaining viscoelastic was washed from the anterior 
chamber 
26.  Sub conjunctival Gentamycin & Dexamethasone injection given 
27.  Pad and bandage applied 
 Post operatively vision, Intraocular pressure measurement with a 
non contact  tonometer was done. All the patients were examined under 
slitlamp examination for the presence of early post operative 
complications such as corneal edema, Inflammation, retained cortical 
material, hypema, decenteration of IOL, pigment dispersion over IOL. 
Topical antibiotic with steroid eye drop was given to all the patients. 
Systemic Antibiotics was given for 5 days. Patients were advised to come 
for regular post operative check up. First visit was one week after post 
operative day. Subsequent visits once in a fortnight till 45 days. 
  
 RESU
Age(yrs)
50-60 
61-70 
71-80 
81-90 
 
    Table 1 shows th
patients were of age 
age group between 
between 71-80 years
years.  
LTS AND OBSERVATION
Table 1.  
Age Distribution: 
 Frequency Pe
8 
23 
17 
2 
 
Figure 1 
Age Distribution 
 
e age distribution of Pseudo exfoli
group between 50-60years. 23(46%) p
61-70 years.17(34%) patients were 
. 2(4%) patients belonged to the age g
50-60
16%
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rcentage 
16 
46 
34 
4 
 
ation. 8(16%) 
atients were of 
of age group 
roup of 81-90 
 Sex 
Male 
Female
 Table 2 shows
patients were males.1
 
Table 2.  
Sex Distribution: 
Frequency Pe
31 
 19 
 
Figure – 2  Sex Distribution 
 
 
 the Sex Distribution of Pseudoexfolia
9(38%) patients were females. 
 
Male
62%
Female
38%
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62 
38 
 
tion. 31(62%) 
  
Laterality
Bilateral
Unilateral
 Table 3 show
22(44%) patients h
unilaterally. 28(56%)
 
Unilat
44%
Table 3  
Laterality 
 Frequency Pe
 28 
 22 
 
 
Figure – 3 
Laterality: 
 
 
s Laterality distribution of pseud
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 patients presented with bilateral distri
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56%
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56 
44 
 
o exfoliation. 
ation material 
bution. 
ral
  
 Table 4 show
2(4%) patients had
an IOP between 13
17mmHg. 24(48%) p
patients had an IOP o
0
5
10
15
20
25
11~13 13-15
IOP (range in mm 
11-13 
13-15 
15-17 
17-19 
19-21 
Table 4  
 IOP Range 
 
Figure 4 
 IOP Range: 
s the range of IOP in Pseudoexfoli
 an IOP of range 11-13mmHg. 11(22%
-15mmg. 2(4%) patients had an IOP
atients had an IOP between 17-19mm
f range 19-21mmHg. 
15-17 17-19 19-21
Frequ
Hg) Frequency Pe
2 
11 
2 
24 
11 
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  Table 5 shows
patients had an assoc
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Ischaemic Heart dise
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4
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10
12
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Systemic Associati
Diabetes mellitus
Hypertension 
IHD 
Others 
Table 5 
 Systemic Association  
 
Figure 5 
 Systemic Association  
 
 
 Pseudoexfoliation & its Systemic asso
iation of Diabetes mellitus. 11(22%) p
pertension. 2(4%) patients had an as
ase. 
 
s 
s
Hypertension IHD Others
on Frequency Per
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ciation. 3(6%) 
atients had an 
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centage 
6 
22 
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  Table 6 show
47(94%) patients had
had PXF along the ir
had Iridodonesis. 10(
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Iris surface
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Associated Pos
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Table 6 
Iris characteristics 
 
Figure 6 
Iris characteristics 
 
s the Iris Characteristics in Pseu
 PXF along the pupillary margin. 15
is surface. 11(22%) patients had Iris A
20%) patients had posterior synechiae
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Frequency Perc
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  Table 7 show
had poor pupillary d
dilation of 5-6mm. 1
 
Pupil diamete
(mm) 
2-4 
5-6 
>6 
Table 7 
Pupil diameter after dilation 
 
Figure 7 
 Pupil diameter after dilation 
 
 
s Pupillary diameter after dilation.10
ilation of 2-4 mm.25(50%)patients had
5(30%) had good pupillary dilation of 
 
2~4
20%
4~6
50%
>6
30%
r 
Frequency Perc
10 
25 
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entage 
20 
50 
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  As shown in 
2(4%) had NS grade
III, 11(22%) had NS
had hyper mature cat
0
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6
8
10
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16
Type of c
Cortical c
Nucleus scler
Nucleus scler
Nucleus scler
Nucleus scler
Mature c
Hypermatur
Tot
Table 8 
Type of cataract: 
 
Figure 8 
Type of cataract 
 
table 8, in our study 1(2%) had co
 I, 9(18%) had NS grade II, 16(32%)
 grade IV, 9(18%) had mature catar
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rtical cataract, 
 had NS grade 
act and 2(4%) 
Percent 
2.0 
4.0 
18.0 
32.0 
22.0 
18.0 
4.0 
100.0 
  Table 9 show
Phacodonesis, 2(4%)
had Zonular dialysis.
 
0
0.5
1
1.5
2
2.5
3
3.5
4
 
Phacodone
Subluxation/dis
Zonular dia
Table 9 
Pre-op risk factors 
 
 
 
Figure 9  
Pre-op risk factors 
 
s Pre-operative risk factors. 4(8%)
 had Subluxation/Dislocation of lens, 
 
 
Frequency Perce
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location 2 
lysis 4 
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 patients had 
4(8%) patients 
Frequency
ntage 
8 
4 
8 
 Difficulty in
Capsulotomy
Yes 
No 
 Table 10 sho
11(22%) patients had
difficulty in capsulot
 
Table 10 
Difficulty in Capsulotomy 
 
 
 
Frequency Perce
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39 
 
Figure 10  
Difficulty in Capsulotomy 
 
ws the Frequency of Difficulty in 
 difficulty in capsulotomy. 39(78%) p
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  Table 11 show
5(10%) patients had 
no difficulty in nucle
 
Difficulty in Nucle
delivery 
Yes 
No 
Table 11 
Difficulty in Nucleus Delivery 
 
Figure 11 
Difficulty in Nucleus Delivery 
 
 
s  the Frequency of Difficulty in Nuc
difficulty in Nucleus delivery.  45(90%
us delivery. 
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No
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leus Delivery. 
) patients had 
centage 
10 
90 
  As shown in t
sphincterotomy done
 
Sphincterotom
done 
Yes 
No 
Table 12  
Sphincterotomy 
 
 
Figure 12  
Sphincterotomy 
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Table 13 
PXF on TM 
 
Figure 13 
PXF on TM 
 
 
ws, in our study 19(38%) patient
n Trabecular meshwork. 
 
38%
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   Table 14 show
8 (16%) patients had
 
Zonular dialysis
Yes 
No 
Table 14 
Zonular dialysis 
 
 
Figure 14 
Zonular dialysis 
 
 
s the frequency of Intra-Operative Zo
 zonular dialysis.  
 
Yes
16%
No
84%
 Frequency Per
8 
42 
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nular Dialysis. 
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16 
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  Table 15 show
patients had posterio
 
PCR 
Absent 
Present 
Table 15 
PCR 
 
Figure 15 
 PCR 
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r capsular rent. 
 
Absent
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16%
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 Table 16 show
Vitreous loss. 
 
Vitreous
Absen
Presen
Table 16 
Vitreous loss 
Figure16 
 Vitreous loss 
 
 
s the frequency of Vitreous loss. 8(16%
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implanted with PCIO
other 4(8%) patients 
 
Table 17 
Type of IOL 
Frequency Percen
 42 84 
L 4 8 
a 4 8 
 
Figure 17 
 Type of IOL 
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 Table 18 show
PXF patients underw
operative complicatio
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Table 18 
Intra Operative Complications 
Figure 18  
Intra Operative Complications 
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 Table 19 show
patients the IOP was
 
 
Normal
Raised
Table 19 
Post Operative IOP 
 
Figure 19: 
Post Operative IOP 
 
s the frequency of post operative IO
 raised. 43(86%) patients had a normal
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 Table 20 show
Pseudoexfoliation pa
had post operative in
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Table 20 
Post operative inflammation 
 
Figure 20  
Post operative inflammation 
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flammation in 
(20%) patients 
Percent 
80.0 
20.0 
  
 Table 21 show
8(16%) patients had 
 
 
Absent 
Present 
Table 21 
Post Operative Corneal Oedema 
 
Figure 21 
Post Operative Corneal Oedema 
 
 
s the frequency of Post Operative Co
post operative corneal Oedema. 
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  Table 22 show
29(58%) patients had
average vision of(6/2
 
6/6
Post OP V/A 
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6/60 ~ 6/24 
< 6/60 
Table 22 
Post OP V/A 
 
 
Figure 22 
 Post OP V/A 
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Table 24 
Preop ZD Vs Intra operative complications: 
 
Preop ZD 
Intra operative complications 
Total 
Absent Present 
 Absent 30 16 46 
 Present 0 4 4 
 Total 30 20 50 
 
Figure 24  
Preop ZD Vs Intra operative complications 
 
 
 
 Table 24 shows The Comparison of Pre operative Zonular dialysis 
with intra operative complications. 
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Table 25 
Pre operative Iridodonesis Vs Intra operative Complications: 
 
 
Figure 25  
Pre operative Iridodonesis Vs Intra operative Complications 
 
 Table 25 shows the comparison of Pre Operative iridodonesis with 
intra operative complications. 
Count 
Intra operative complications 
Total 
Absent Present 
Absent 30 17 47 
Present 0 3 3 
Total 30 20 50 
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Table 26 
Phacodonesis Vs Intra operative complications 
 
Count 
Intra operative complications 
Total 
Absent Present 
Absent 30 16 46 
Present 0 4 4 
Total 30 20 50 
 
Figure 26  
Phacodonesis Vs Intra operative complications 
 
 Table 26 shows the comparison of pre operative phacodonesis with 
intra operative complications. 
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Table 27 
Type of cataract Vs Presence of post op complication: 
Type 
Presence of post op 
complication Total 
Absent Present 
Cortical cataract 1 0 1 
Nucleus sclerosis grade 1 2 0 2 
Nucleus sclerosis grade  2 7 2 9 
Nucleus sclerosis grade 3 12 4 16 
Nucleus sclerosis grade 4 3 8 11 
Mature cataract 4 5 9 
Hypermature cataract 1 1 2 
Total 30 20 50 
 
Figure 27  
Type of cataract Vs Presence of post op complication 
 
 
 Table 27 shows the comparison of Type of cataract Vs Presence of 
post op complication. 
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DISCUSSION 
This study comprises of 50 patients with pseudoexfoliation who 
underwent small incision cataract surgery at department of 
ophthalmology, Coimbatore medical college hospital, Coimbatore during 
the period of August 2013 – July 2014. 
In this study as shown in table 1, there were 8(16%) patients with 
PEX belonging to age group of 50-60 yrs, 23(46%) patients with PEX of 
age group 61-70 yrs, 17(34%) patients of age group 71-80 yrs, 2(4%) 
patients of age group 81-90 yrs.  The mean age of presentation in the 
study was found to be 69.24 years and majority 42(84%) out of 50 were 
above 60 years of age. 
This finding was consistent with many more studies that showed 
that the pseudo exfoliation a senile condition and its prevalence increase 
with ageing. 
Table 2 shows, 31(62%) patients with pseudo exfoliation who 
underwent cataract surgery were males and 19(38%) patients with pseudo 
exfoliation were females. The male to female ratio was found to be nearly 
3:2 with male predominance. Various studies conducted by several 
authors across the world regarding the sex distribution of pseudo 
exfoliation were still conflicting. Some series of studies show male 
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predominance while some other studies show female predominance. This 
could be possibly explained by the factor that pseudo exfoliation occurs 
in those who were predominately involved in outdoor activities compared 
with those engaged in indoor activities. 
As shown in table 3, regarding the laterality of pseudo exfoliation 
28(56%) were found to have bilateral occurrence and 22(44%) had 
pseudo exfoliation unilaterally. On reviewing the literature, for the 
frequency of monocular Vs binocular involvement of pseudo exfoliation, 
it was found binocular involvement to be more common than monocular 
involvement. 
The ultra structural study conducted by Naumann, Schlotzer-
Schrehardt, Hammer (2001) on the contralateral eye of donor eyes with 
unilateral pseudo exfoliation showed the presence of pseudo exfoliation 
material in the anterior segment of all the eyes. They concluded that 
pseudo exfoliation was a bilateral disease with asymmetrical 
involvement. Even though the reason for asymmetry was unknown, they 
suggested that unilateral occurrence was a precursor for the bilateral 
presentation which occurs within 5-10 years. 
As shown in table 4, the range of intraocular pressure in the present 
study was found to be between 11-21 mm of Hg. The mean IOP was 
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17.09 mmHg on comparing with normal mean IOP (15.5 mmHg), this 
was found to be quite high. Eyes with pseudo exfoliation were at a 
cumulative risk for glaucoma, it was found to be 5% and 15% at 5 years 
and 10 years respectively
7
. This obviates the need for careful follow –up 
of the patients with pseudo exfoliation. Also, the patients with unilateral 
pseudo exfoliation glaucoma and only pseudo exfoliation material in the 
other eye were at high risk (50% chance) of developing glaucoma, on the 
other hand the absence of pseudo exfoliation in the other eye  lowers the 
risk of glaucoma in that eye
7
.  
However this study did not include the patients of PXF with raised 
IOP since the aim was to study purely the intra-operative and 
postoperative complications caused by pseudo exfoliation and if included 
it may affect the visual outcome. 
Table 5 shows, pseudo exfoliation and its systemic association. It 
was found that 3 (6%) patients with pseudo exfoliation had an associated 
diabetes mellitus, 11 (22%) had an associated hypertension, 2 (4%) had 
an associated Ischaemic heart disease.  
The significance of the association could not be assessed since 
there was no control group in our study. Also majority of the patients of 
our study were from camps who visited the hospital for the first time. So 
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there may be a chance of underlying any asymptomatic systemic 
association that was not detected.  
Table 6 shows, the characteristic changes of iris in pseudo 
exfoliation patients. 47 (94%) had the presence of pseudo exfoliation 
material along the pupillary margin, 15 (30%) over the surface of iris, 11 
(22%) of patients were noted with Iris atrophy, 3 (6%) of patients had 
iridodonesis and 10 (20%) had the presence of posterior synechiae. The 
present study is in concurrent with the study made by Ritch Schlotzer. 
Also in 2001, Scherhardt
88
 et al stated that the presence of pseudo 
exfoliation along the pupillary margin is seen in nearly 84% of patients. 
More over the presence of pseudo exfoliation material along the iris 
sphincter is considered to be more consistent and prominent clinical 
finding next to the lens pseudo exfoliation material. 
As shown in table 7, 10 (20%) of patients with pseudo exfoliation 
had a very poor mydriasis of < 4mm, 25 (50%) of patients with pseudo 
exfoliation had mydriasis of 5-6mm which is fair and nearly 15 (30%) 
had a good mydriasis of more than 6mm. 
Patients with pseudo exfoliation were more prone for insufficient 
mydriasis. This was consistent with the other studies made by various 
authors. 
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In 1990 Freyler H, Radax U found pupillary dilation less than 4mm 
in 19 out of 32 pseudo exfoliation patients who underwent cataract 
surgery
81
. 
In 1996 Stanila A found quite a lot of patients with pseudo 
exfoliation with poor pupillary dilation
82
. 
Asano N, Schlotze-Scherhardt, Naumann (1966) studied the iris 
characteristics of pseudo exfoliation patients in detail and suggested that 
the poor mydriasis was found to be due to degenerative change in 
pupillary muscle fibers including both dilator and sphincter muscle cells 
account for the insufficient mydriasis
89
.  
Also in 1966 Repo L.P et al remarked that the poor mydriasis was 
due to the degenerative changes in both the muscular layer of iris and in 
stromal tissue
68
. 
Alfaite et al (1966) observed significant poor mydriasis (P value < 
0.001) in their study. They found that the pseudo exfoliation material gets 
accumulated over the iris surface and results in reduction of stromal 
elasticity which plays a much significant role in insufficient mydriasis. 
Mohammad Jawad et al (2009) noticed 48% with poor pupillary 
dilation (2-4 mm) 42% with fair pupillary dilation (5-6mm) and 10% with 
good dilation (7-9mm)
90
. 
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Surekha et al (2012) studied the eyes of pseudo exfoliation patient 
and found 26% of patients with poor pupillary dilatation 
As shown in table 8, out of 50, 1 (2%) patient with pseudo 
exfoliation had cortical cataract, 11 (22%) patients with early nuclear 
selerosis including grade I and grade II. 38 (86%) patents had an 
advanced cataract including nuclear selerosis grade III and IV, mature 
and hyper mature cataract.  
Higher incidence of nuclear cataract and smaller incidence of 
cortical and supra nuclear opacities were noted by seland JH chylack LT 
(1982)
10
. 
Hietanen J et al also reported that nuclear cataract was the 
predominant type of cataract in their study. 
In 2001Ritch R Schlotze-Scherhardt suggested an increased 
occurrence of nuclear cataract in pseudo exfoliation patients. As noticed 
by other authors, the present study also had an increased number of 
advanced cataracts
88
. 
 The present study shows 7(14%) patients of pseudo exfoliation 
had pigment dispersion.  
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IN 2004 Kuldar et al noted 34% pigment dispersion on anterior 
surface of lens and 17.4% on the posterior surface of cornea. The pigment 
dispersion is due to the release of iris pigment granules from the 
atrophied pigment epithelium
91
. 
The released iris pigments may be seen as deposited on the 
endothelium known as Krukenberg spindle. None of the patients in the 
present study had this type of distribution of pigments.  
In 1986 Prince, A.M, Ritch R proposed that after mydriasis the iris 
pigments released into the anterior chamber attains a whorl like pattern 
and gets deposited over the iris sphincter and peripheral iris
53
.  
In 2000, Ritch R, Schlotzer-Scherhandt noted that patients with 
pseudo exfoliation had profuse pigment dispersion in anterior chamber 
after pupillary dilatation. He also added that the presence of pigment 
granules after pupillary dilatation was one of the suspicious sign to look 
for pseudo exfoliation syndrome in pre clinical stages.  
The present study shows 4(8%) patients of pseudo exfoliation with 
phacodonesis.  In 1989 Futa R. Furnyoshi observed an incidence of 8%. 
In 1993 Moreno J., Duch S., Harara J noted an incidence of 10.6% 
of phacodonesis.  This is due to the instability of the weakened zonules. 
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As shown in table 9, 2 (4%) patients with pseudo exfoliation had 
subluxation dislocation and 4(8%) had preoperative zonular dialysis. 
Poor pupillary dilatation, phacodonesis,  subluxation/dislocation of 
cataractous lens and Zonular dialysis were considered to be the most 
important risk factors since these factors lead to a rise in intra operative 
complications.  
As shown in table 10, difficulty in anterior capsulotomy was noted 
in 11(22%) patients. The patients were managed by stretching the pupil 
manually or by performing a sphincterotomy.  
Table 11 shows, in 5(10%) patients with pseudo exfoliation, there 
was difficulty in nucleus delivery. The most important reason behind this 
is the presence of large and hard nucleus. 
As shown in table 14, 15 and 16, 8(16%) patients with pseudo 
exfoliation had intra operative zonular dehiscence. 8(16%) patients had 
posterior capsule rupture and 8(16%) had vitreous loss.  
Several studies conducted by various authors also showed the 
occurrence of zonular dehiscence, Posterior capsule rupture and Vitreous 
loss intra operatively in patients with pseudo exfoliation to be significant.  
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In 1989 Schonherrs U et al reported that the chances of intro 
operative and post operative complications in patients with pseudo 
exfoliation undergoing cataract surgery were found to be statistically 
significant. 
 In 1998 Scrolloli et al reported that patients with pseudo 
exfoliation were five times at high risk for development of intraoperative 
complications during cataract surgery compared to normal cataract. 
In 1990 Freyler H,  Radar U reported in his study that out of 36 
patents 26 with pseudo exfoliation syndrome had intra operative 
complications like Zonular dehiscence, posterior capsular rupture and 
Vitreous loss which further lead on to post operative complications like 
de-centeration of  IOL, corneal edema and inflammation
81
. 
Other studies which offers a significant intra-operative 
complications in patients with pseudo exfoliation includes  
a) Holding G (1998) reported the incidence of zonular dehiscence 
as 18% 
b) Avramides S (1997) reported it as 13% 
c) Lumme P, Laatikanan (1993) reported it as 15% 
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Regarding posterior capsular rent and vitreous loss, Stanila (1996) 
noted that there was an increased incidence of posterior capsular rent and 
vitreous loss in their study. 
In 2000 Kuchle et al noted 6.9% of incidence of intra-operative 
complications such as zonular dehiscence and vitreous loss
80
. 
In 2001 Ritch R reported that the presence of zonular fragility 
increases the intra-operative complications like Dislocation of lens, 
Zonular dehiscence and Vitreous loss to tenfold
88
. 
In 1993 Lumme P, Laatikanen L noted that Vitreous loss was 
fourfold more in pseudo exfoliation eyes and the chance of posterior 
capsular rupture was tenfold higher in pseudo exfoliation patients 
underwent cataract surgery
77
. 
Similarly, in 1997 Avramides S, Travamidies P, Sakkias G in their 
study of 84 patients with pseudo exfoliation undergoing cataract surgery 
found the occurrence of posterior capsular rupture was 10.4% and 
Vitreous loss was 7.14%. 
Also Junemann, Martus. P et al noted an incidence of 6.7% 
vitreous loss in eyes with pseudo exfoliation syndrome undergoing 
cataract sugery. 
 
 
Page | 99  
 
In 1978 Naumann G.O., Kuchle M., Schonher U reported a seven 
fold increase of vitreous loss and 4.2% incidence of posterior capsular 
rupture in eyes with pseudo exfoliation undergoing cataract surgery. 
As shown in table 23 on comparing the pupillary diameter with 
intra-operative complications. Out of 8 patients with posterior capsular 
rupture 6 (75%) had insufficient mydriasis compared to 2 (25%) who had 
sufficient pupillary dilatation. Regarding vitreous loss out of 8 patients, 6 
(75%) had insufficient mydriasis whereas 2 (25%) had adequate pupillary 
dilatation. Out of 8 patients who had zonular dialysis, all these patients 
had an insufficient mydriasis. 
On comparing the size of pupillary diameter with intra-operative 
complications a significant correlation (P = 0.021) was obtained. 
Also there was a significant correlation between the size of 
pupillary diameter and post operative complications (P = 0.016). 
The present study correlates well with the other studies conducted 
by Freyler H., Radax U (1990), Stanilla A (1996), Repo L.P. et al (1996), 
Asano N. et al (1996) and Avramides S et al (1997). 
In 2002, Vickie Lee and Anthony Maloof did an exclusive study on 
small pupils and their management in cataract surgery. They suggested 
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that the poorly dilated pupils can be managed by prosthetic and non-
prosthetic methods
83
. 
Since the prosthetic methods are unavailable in our setup, most of 
the cases with poor pupillary dilatation are managed either by 
sphincterotomy, visco-mydriasis, and by manual iris stretching. 
As shown in table 17, 42 (84%) patients were implanted with 
posterior chamber intraocular lens, 4 (8%) patients were implanted with 
IOL on sulcus. 4 (8%) patients were left aphakic since there was no 
adequate capsular support. These cases can be managed secondarily with 
sclera fixated intraocular lens after doing an anterior vitrectomy. 
In the present study, as shown in table 19, 7 (14%) patients with 
pseudo exfoliation who underwent cataract surgery had a rise in 
intraocular pressure post-operatively. Similar result of postoperative 
increase in IOP was found in 15.6% in a study conducted by Abid 
Naseem et al. 
In 1989 Krupin T, Feiti ME, Bishop K studied the postoperative 
intraocular pressure changes in PEX patients who underwent cataract 
surgery. He reported that the patients with pseudo exfoliation are at high 
chance of raised intra ocular pressure in the immediate post operative 
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period. So, he suggested all viscoelastic substances should be removed 
thoroughly during the time of surgery. 
He also added that the PEX patients with field loss and advanced 
glaucomatous changes should be monitored 4
th
 hourly for IOP and it 
should be effectively managed. 
As shown in table 20, the present study shows postoperative 
inflammation in 10 (20%) patients. The chances of getting a fibrinoid 
reaction in the post operative period was due to breakage of blood-
aqueous barrier which can happen preoperatively or intra-operatively due 
to improper handling in an inadequately dilated pupil. Also it can be due 
to the retained lens material. 
As shown in table 21, in our study 8 (16%) patients with pseudo 
exfoliation who underwent cataract surgery had corneal edema 
postoperatively. 
Abid Naseem et al showed in their study the incidence of post 
operative corneal edema was 43.8%. Yet another study done by 
K.Pranathi et al showed 11.5% of post operative corneal edema. 
As shown in table 21, the present study shows a visual acuity of 
6/6 – 6/18 in 29 (58%) patients with pseudo exfoliation who underwent 
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cataract surgery. 12 (24%) patients had 6/60 – 6/18 vision. Remaining 9 
(18%) patients had poor visual acuity of less than 6/60. 
Our study shows 5 (10%) of patients with dislocation of IOL in the 
immediate post operative period. 6 (12%) of patients showed iris pigment 
dispersion over IOL. 
Limitations of our study were a control group was not available for 
comparison. Even though, follow-up period was planned for 45 days, 
since most of our patients were from remote areas, they could not be 
followed up for post operative complications. Hence, the immediate 
postoperative complications alone were included in the study. 
Also it was a small-scale cross sectional descriptive study and it 
requires a large scale study to test the findings in huge population. 
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SUMMARY 
The study titled “Perioperative Complications in patients with 
Pseudoexfoliation undergoing small incision cataract surgery” done at 
Department of Ophthalmology, Coimbatore Medical College Hospital, 
Coimbatore during the period of August 2013-July 2014 includes 50 
patients. 
The mean age of presentation in the study was found to be 69.24 
years and majority 42(84%) out of 50 were above 60 years of age. The 
male to female ratio was found to be nearly 3:2 with male predominance. 
It was found binocular involvement to be more common than monocular 
involvement. The mean IOP was 17.09 mmHg, on comparing with 
normal mean IOP (15.5 mmHg), this was found to be quite high. 
The significance of the systemic association could not be assessed 
since there was no control group in our study. Patients with pseudo 
exfoliation were more prone for insufficient mydriasis. This was 
consistent with the other studies made by various authors. 38 (86%) 
patents had an advanced cataract including nuclear sclerosis grade III and 
IV, mature and hyper mature cataract. On comparing the size of pupillary 
diameter with intra-operative complications a significant correlation (P = 
0.021) was obtained. 
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Also, the present study showed that the poor mydriasis, Pre 
operative Zonular dialysis, Iridodonesis, Phacodonesis and type of 
cataract were the most common risk factors that affect the surgical 
outcome.  
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CONCLUSION 
The following conclusions were drawn from the study 
 Patients with Pseudoexfoliation syndrome and cataract posted for 
small incision cataract surgery, have to be carefully looked for Zonular 
weakness, insufficient mydriasis, Phacodonesis, Subluxation/Dislocation 
of cataractous lens because these preoperative risk factors can alter the 
surgical outcome. 
Inadequate mydriasis, one of the major pre operative risk factor in eyes 
with Pseudoexfoliation syndrome which has a bearing on the intra 
operative complications like posterior capsular rent and vitreous loss. 
Adequate surgical modifications such as Sphincterotomy, Synechiolysis 
and manual stretching of pupil increase the pupil size and reduce the intra 
operative complications. 
All though Cataract surgery in Pseudoexfoliation is challenging, if the 
surgeon is aware of the condition pre operatively and pays meticulous 
attention to the surgical technique during small incision cataract surgery, 
the intraoperative complications can be managed and good outcome can 
be expected. 
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1
ST
 POST OP DAY: 
1. TEST VISION 
2. IOP 
3. SLIT LAMP EXAMINATION 
Corneal edema 
Inflammation 
Dislocation of IOL 
Pigment dispersion 
NEXT VISIT  
1. TEST VISION 
2. IOP 
3. SLIT LAMP EXAMINATION 
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CONSENT FORM 
 
 Here by I volunteer and to participate in this study 
“PERIOPERATIVE COMPLICATIONS IN PATIENTS WITH 
PSEUDOEXFOLIATION UNDERGOING SMALL INCISION 
CATARACT SURGERY”. I was fully explained about the nature of 
this study by the doctor, knowing which I 
Mr/Mrs____________________________ fully consent to volunteer in 
this study. 
 
 
Date: 
Place:                                      Signature of the volunteer 
                    
                                             Signature of Witness 
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xg;g[jy;  gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah; : 
ghypdk; :      taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; fz; kUj;Jt Jiwapy; 
gl;l nkw;gog;g[ gapYk; khztp mth;fs; nkw;bfhs;Sk; 
"Nnlhvf;!; @nghypna#d; cila nehahspfSf;F fz;g[iu 
mWit rpfpr;ir bra;a[k; nghJk;/ gpwFk; Vw;gLk; tpist[fs; " 
Fwpj;j Ma;tpy; bra;Kiw kw;Wk; midj;J tptu';fisa[k; 
nfl;Lf; bfhz;L vdJ re;njf';fis bjspt[g;gLj;jpf; 
bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpy; ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
,lk;  :       ifbahg;gk; / nuif 
ehs; : 
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KEY TO MASTER CHART 
IP No  –  Inpatient number 
UL/BL  –  Unilateral/Bilateral 
N  –  Normal 
N+  -  Normal surface with presence of PXF material on 
surface 
PM  –  PXF on pupillary margin 
PS  –  Posterior synechiae 
RTL  –  Reacting to Light 
SRTL  –  Sluggishly reacting to light 
PID  –  Pigment dispersion 
NS  –  Nuclear sclerosis 
PSC  –  Posterior subcapsular cataract 
MC  –  Mature cataract 
HMC  –  hyper mature cataract 
Pz  –  PXF material on peripheral zone of anterior capsule 
Cz  -  PXF material on central zone of anterior capsule 
PD  –  Phacodonesis 
SL/DL  –  Subluxation/Dislocation 
ZD  –  Zonular dialysis 
IOP  –  Intraocular Pressure 
DM  –  Diabetic mellitus 
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HT  –  Hypertension 
IHD  –  Ischaemic heart disease 
ID  –  Iridodonesis 
CC  –  Cortical cataract 
PxM  –  PXF material present in trabecular meshwork 
PxS  –  PXF material present in schwalbes line 
SICS  –  Small incision cataract surgery 
PCIOL  –  Posterior chamber intraocular lens 
IOLIS   -  Intraocular lens in sulcus 
Sph  –  Sphinterotomy 
DC  –  Difficulty during anterior capsulotomy 
DN  –  Difficulty during nucleus delivery 
CET  –  Corneal endothelial touch 
PCR  –  Posterior capsular rent 
VL  –  Vitreous loss 
UCVA  –  Uncorrected visual acquity 
I  –  Increased 
IFN  – Inflammation 
CE  –  Corneal Edema 
DI  –  Dislocation of IOL 
IPD  –  Iris Pigment dispersion 
CFCF  –  Counting fingers close to face 
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DI PS IPD 
1 shanmugam 42569 53 M UL 3/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 5 0 NS II 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/12 N 0 0 0 0   0 
2 Natesan 42671 62 M BL 3/60 20.6 0 0 0 0 N1 1 1 1 0 3 RTL 5 1 NSIV 1 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/36 I 1 0 0  0 0  
3 Rangasamy 44317 70 M UL 5/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 6 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
4 kuppayammal 44567 75 F BL PL1 20.6 0 0 0 0 N1 1 0 1 1 3 SRTL 5 0 MC 1 1 0 1 OPEN 1 1 SICS PCIOL 1 1 1 1 1 1 0 0 1/60 I 1 1 1  1  0 
5 kannimuthu 44764 63 M BL 6/60 14.6 0 0 0 0 N1 1 0 0 0 3 RTL 4 0 NSIII1PSC 1 0 0 0 OPEN 1 0 SICS IOLIS 1 0 0 0 0 0 1 1 2/60 I 1 1 0 0  0  
6 Lakshmi 32157 73 F BL 3/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 5 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/12 N 0 0 0 0  1 
7 Valliathal 32254 70 F BL 1/60 20.6 0 1 0 0 N 1 0 0 0 2 RTL 4 0 NSIII1PSC 1 0 0 0 OPEN 1 0 SICS PCIOL 1 1 0 0 0 0 0 0 6/24 N 0 0 0 0   0 
8 Palanathal 56734 70 F BL 5/60 13.3 0 1 0 0 N 0 0 0 0 3 RTL 6 0 NSIII 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/18 N 0 0 0 0  0  
9 Chinnapan 57908 68 M UL 4/60 17.3 0 1 0 0 N 0 1 0 0 2 RTL 4 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 1 1 0 0 0 0 0 0 6/18 N 0 0 0 0  0  
10 Singaravelu 47869 75 M BL CFCF 19.3 0 0 0 0 N1 1 1 1 0 3 RTL 5 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 1 1 0 0 0 0 6/24 N 0 1 0 0   0 
11 Karuppan 67528 73 M BL 3/60 20.6 0 1 0 0 N 1 0 0 0 3 RTL 6 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 5/60 I 0 0 0  0  1 
12 Ramasamy 68489 60 M UL 4/60 17.3 0 0 0 0 N 1 1 0 0 3 RTL 5 0 NSIII 1 0 0 0 OPEN 0 0 SICS APHAKIA 1 0 0 0 0 0 1 1 1/60 N 0 1 0 0   0 
13 Karuppayammal 70349 80 F BL 1/60 17.3 0 0 0 0 N1 1 1 1 0 3 RTL 7 1 MC 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/36 N 0 0 0  0  0 
 14 Palani  71993 85 M UL PL1 17.3 0 0 0 0 N 1 1 1 0 3 RTL 6 1 MC 0 1 0 1 OPEN 1 0 SICS IOLIS 0 0 0 1 0 0 1 1 6/24 N 1 0 0  0 0  
 15 Mariyammal  73986 62 F BL CFCF 13.3 0 1 0 0 N 1 1 0 0 2 RTL 4 0 MC 1 0 0 0 OPEN 1 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
 16 Cinnamani  75682 68 F UL 1/60 17.3 0 1 0 0 N 1 1 0 0 3 RTL 4 1 NSII1PSC 0 0 0 0 OPEN 1 1 SICS PCIOL 1 0 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
17 Angammal 76895 68 F UL 6/36 14.6 0 0 0 0 N 1 1 0 0 2 RTL 4 0 NSIII 1 0 0 0 OPEN 0 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/18 N 0 0 0 0   0 
18 Kaliyammal 77654 73 F UL 1/60 19.3 0 0 1 0 N 1 0 0 0 3 SRTL 5 0 NSIII 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 3/60 N 0 0 0 0   0 
19 pappathi 79567 75 F UL HM 20.6 0 0 0 0 N 1 0 1 1 3 SRTL 6 1 MC 1 1 0 1 OPEN 1 1 SICS PCIOL 0 0 1 1 0 0 0 0 CFCF N 1 0 1  0 0  
20 paranjothi 86754 68 M BL 2/60 17.3 0 0 1 0 N 1 1 0 0 3 RTL 8 0 NSII1PSC 1 0 0 0 OPEN 1 1 SICS PCIOL 0 1 0 0 1 1 0 0 6/12 N 0 0 0  0 0  
21 palanivel 89704 65 M UL 5/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIII 1 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/18 N 0 0 0 0   0 
22 Veerasamy 89935 67 M UL 3/60 13.3 0 0 0 0 N 1 0 0 0 3 RTL 5 0 NSIII 1 0 0 0 OPEN 1 0 SICS PCIOL 0 1 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
23 Chellamuthu 91023 65 M UL 5/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIII 1 0 0 0 OPEN 0 0 SICS PCIOL 0 1 0 0 1 0 0 0 6/9 N 0 0 0 0   0 
24 Ramalan bevi 92567 75 F BL PL1 18.9 0 1 0 0 N 1 0 0 0 3 RTL 5 0 HMC 1 0 0 0 OPEN 1 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/24 N 1 0 0 0   0 
25 Kuppusamy 96743 70 M BL 3/60 13.3 0 0 0 0 N1 1 0 1 0 3 RTL 7 0 NSIV 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/18 N 0 0 0  0 0  
26 Muppathal 98211 65 F BL 5/60 17.3 0 0 0 0 N 1 0 0 0 2 RTL 4 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 1 1 0 0 1 0 0 0 6/60 I 1 0 0  0 0  
27 Kupammal 98371 68 F BL 5/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIII 1 0 0 0 OPEN 0 0 SICS APHAKIA 0 0 0 0 0 0 1 1 1/60 I I 0 0 0  0  
28 Mustafa 98450 62 M UL 2/60 18.9 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIII 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/12 N _ 0 0 1 1 
29 Pitchai 98500 60 M UL 4/60 13.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
30 Karuppasamy 99321 65 M BL 4/60 17.3 0 0 0 0 N1 1 1 1 0 3 RTL 5 1 NSIII 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 1 0 0 0 0 6/36 N 0 0 1 0  0  
31 Patchaimuthu 10018 58 M UL 3/60 14.6 1 0 0 0 N 1 0 0 0 3 RTL 8 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/12 N 0 0 0 0   0 
32 Arunachalam 10287 63 M BL 6/60 14.6 0 0 0 0 N 1 0 0 0 3 RTL 5 0 NSII1PSC 1 0 0 0 OPEN 1 0 SICS PCIOL 1 1 0 0 0 0 0 0 6/18 I 0 0 1 0  0  
33 Palaniammal 11765 65 F UL 5/60 12.2 0 0 0 0 N1 1 0 0 0 3 SRTL 5 0 NSIII 1 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/9 N 0 0 0 0   0 
34 Muthupetchi 12034 55 F BL 5/60 17.3 0 0 0 0 N 1 0 0 0 2 RTL 8 0 CC 1 0 0 0 OPEN 1 0 SICS IOLIS 0 0 0 0 0 0 1 1 6/18 N 0 0 0 0  0  
35 Vellaiyan 12987 87 M BL PL1 20.6 0 0 0 0 N 1 0 1 1 3 SRTL 5 1 HMC 1 1 0 1 OPEN 1 0 SICS PCIOL 1 0 1 1 0 0 0 0 6/18 N 0 0 0 0   0 
36 Muthuvel 13623 78 M BL 2/60 20.6 0 1 0 0 N 1 0 1 0 3 RTL 7 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/36 N 0 0 0 0  0  
37 Kalisamy 13976 65 M UL 1/60 17.3 0 0 0 0 N1 1 0 0 0 3 RTL 6 0 NSIII 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/6 N 0 0 0 0   0 
38 Parvathy 28796 58 F BL 3/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIII 0 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/18 N 0 0 0 0  0  
39 Kumarasamy 30562 53 M UL 6/60 14.6 1 0 0 0 N 1 0 0 0 3 RTL 5 0 NSII 1 0 0 0 OPEN 0 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/12 N 0 0 0 0  0  
40 Ammasi 30612 79 M BL CFCF 14.6 0 0 0 0 N 1 0 0 0 3 RTL 5 0 MC 1 0 1 0 OPEN 0 0 SICS APHAKIA 1 1 1 1 1 1 1 1 1/60 I 1 1 1 0   0 
41 Ayyavu 39527 76 M UL HM 17.3 0 1 1 0 N1 1 0 0 0 3 RTL 6 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/18 N 0 0 0 0  0  
42 Marappan 40098 80 M BL 1/60 20.6 0 0 0 0 N1 1 0 0 0 3 RTL 4 0 NSIV 1 0 0 0 OPEN 1 1 SICS PCIOL 1 0 0 0 0 0 0 0 6/12 N 0 0 0 0  1 
43 Saraswathy 41956 67 F BL 3/60 17.3 0 0 0 0 N 1 0 0 0 3 RTL 8 0 NSII1PSC 1 0 0 0 OPEN 0 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/12 N 0 0 0 0  0  
44 Kamatchi 45812 77 F UL CFCF 17.3 0 1 0 0 N 1 0 0 0 3 RTL 5 0 NSIV 1 0 0 0 OPEN 1 0 SICS PCIOL 0 0 0 0 0 0 0 0 6/60 N 1 1 0 0  0  
45 Rangasamy 49321 85 M BL HM 15.9 0 0 1 0 N 1 0 1 0 2 SRTL 5 0 MC 1 0 1 0 OPEN 1 0 SICS APHAKIA 0 1 1 1 1 1 1 1 CFCF N 0 1 0 0  0  
46 Kannaiyan 50034 60 M UL 5/60 12.2 0 1 0 0 N1 1 0 0 0 3 RTL 8 0 NSIII 1 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/9 N 0 0 0 0  0  
47 Anthoni 57682 75 M BL 3/60 17.3 0 0 0 0 N1 1 0 0 0 3 RTL 5 0 NSIV 1 0 0 0 OPEN 1 0 SICS IOLIS 0 0 0 0 0 0 1 1 6/24 N 0 1 0 0  0  
48 Muniappan 60067 77 M UL 3/60 20.6 1 0 0 0 N 1 0 0 0 3 RTL 8 0 NSIV 1 0 0 0 OPEN 1 1 SICS PCIOL 0 0 0 0 0 0 0 0 6/60 I 1 1 0 0  1 
49 Maral 69321 78 F BL PL1 17.3 0 0 0 0 N1 1 0 0 0 3 RTL 4 0 MC 1 0 0 0 OPEN 0 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/12 N 0 0 0 0  1  
50 Vellingiri 69923 78 M BL CFCF 14.6 0 0 0 0 N1 1 0 0 0 3 RTL 4 0 MC 1 0 0 0 OPEN 0 0 SICS PCIOL 1 0 0 0 0 0 0 0 6/18 N 0 0 0 0  0  
 
